Skip to content
value.today

HistoSonics, Inc.

🇺🇸 Fowlerville, Michigan, USABiotechnologyFounded 2009
Total raised
$216 M
7 rounds on record
Latest round
$102 M
Jul 2024
First round on record
Dec 2009
Today
Private
No later event on record

Funding rounds

7 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of HistoSonics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2024$102 MNo. 7$50 to $250 million

HistoSonics, Inc.: Raise no. 7, Jul 2024

Investors in this round

39 investors had bought by the notice of Aug 15, 2024: 39 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$102 M of $102 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Michael Blue · Executive Officer, Director
  • Chris Dimitropoulos · Director
  • Erica Kadir Rogers · Director
  • Fred Kadir Lee, Jr. · Director
  • Gerry Kadir Brunk · Director
  • James Adox · Director
  • Tom Kadir Tefft · Director
  • V. Kadir Kadhiresan · Director
  • Wen Kadir Chen · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Dave Krenn, Cfo. Source: SEC Form D, newest notice filed Aug 15, 2024. Read the notice at the SEC.

equitySEC
Apr 2020$41 MNo. 6$10 to $50 million

HistoSonics, Inc.: Raise no. 6, Apr 2020

Investors in this round

24 investors had bought by the notice of Jun 12, 2020: 24 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$41 M of $41 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Michael Blue · Executive Officer, Director
  • Richard Eric Bosler · Executive Officer
  • Fred Lee · Director
  • Gerry Brunk · Director
  • James Adox · Director
  • Kadir Kadhiresan · Director
  • Nikita Kulkarni · Director
  • Thomas Tefft · Director
  • Wen Chen · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael Blue, President and CEO. Source: SEC Form D and 1 amendment, newest notice filed Jun 12, 2020. Read the notice at the SEC.

equitySEC
Apr 2019$47 MNo. 5$10 to $50 million

HistoSonics, Inc.: Raise no. 5, Apr 2019

Investors in this round

44 investors had bought by the notice of Apr 11, 2019: 44 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$47 M of $47 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Michael Blue · Executive Officer, Director
  • Fred Lee · Director
  • Gerry Kadir Brunk · Director
  • Gregory Sorensen · Director
  • James Adox · Director
  • Tom Tefft · Director
  • V. Kadir Kadhiresan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael Blue, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 11, 2019. Read the notice at the SEC.

equitySEC
Jan 2017$8 MNo. 4$2 to $10 million

HistoSonics, Inc.: Raise no. 4, Jan 2017

Investors in this round

13 investors had bought by the notice of Feb 8, 2017: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $13 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • M. Christine Gibbons · Executive Officer
  • Michael Christine Blue · Executive Officer, Director
  • Andrew Christine Von Eschenbach · Director
  • Fred Christine Lee, Jr. · Director
  • James Christine Adox · Director
  • Renard Christine Charity · Director
  • Robert Christine Morff · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by M. Christine Gibbons, COO, Secretary, Treasurer. Source: SEC Form D, newest notice filed Feb 8, 2017. Read the notice at the SEC.

equitySEC
Jul 2015$2 MNo. 3$2 to $10 million

HistoSonics, Inc.: Raise no. 3, Jul 2015

Investors in this round

10 investors had bought by the notice of Aug 10, 2015: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $3 M offered; $1 M still to sell
Smallest investment taken
$15,000
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • M. Christine Gibbons · Executive Officer, Director
  • Thomas Christine Davison · Executive Officer, Director
  • Andrew Christine Von Eschenbach · Director
  • James Christine Adox · Director
  • Renard Christine Charity · Director
  • Robert Christine Morff · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by M. Christine Gibbons, President and CEO. Source: SEC Form D, newest notice filed Aug 10, 2015. Read the notice at the SEC.

debt, optionsSEC
Dec 2014$2 MNo. 2Under $2 million

HistoSonics, Inc.: Raise no. 2, Dec 2014

Investors in this round

8 investors had bought by the notice of Dec 23, 2014: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
$18,750
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • M. Christine Gibbons · Executive Officer, Director
  • Thomas Christine Davison · Executive Officer, Director
  • Andrew Christine Von Eschenbach · Director
  • James Christine Adox · Director
  • Renard Christine Charity · Director
  • Robert Christine Morff · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by M. Christine Gibbons, President and CEO. Source: SEC Form D, newest notice filed Dec 23, 2014. Read the notice at the SEC.

debt, optionsSEC
Dec 2009$14 MNo. 1$10 to $50 million

HistoSonics, Inc.: Raise no. 1, Dec 2009

Investors in this round

13 investors had bought by the notice of May 19, 2014: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$14 M of $14 M offered; $0 M still to sell
Smallest investment taken
$10,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • M. Christine Gibbons · Executive Officer, Director
  • Thomas Christine Davison · Executive Officer, Director
  • Andrew Christine Von Eschenbach · Director
  • James Christine Adox · Director
  • Renard Christine Charity · Director
  • Robert Christine Morff · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by M. Christine Gibbons, President and CEO. Source: SEC Form D and 4 amendments, newest notice filed May 19, 2014. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • HistoSonics, Inc. chose not to state its revenue in its newest notice of a funding round (Aug 2024).

    SEC Form D · Aug 2024

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Aug 2024

That is all the official record says: HistoSonics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of HistoSonics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 7 rounds above had up to 44 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by HistoSonics, Inc.
NameRoleNamed in
Michael BlueExecutive officerAug 2024
Richard Eric BoslerExecutive officerJun 2020
M. Christine GibbonsExecutive officerFeb 2017
Michael Christine BlueExecutive officerFeb 2017
Thomas Christine DavisonExecutive officerAug 2015
Chris DimitropoulosDirectorAug 2024
Erica Kadir RogersDirectorAug 2024
Fred Kadir Lee, Jr.DirectorAug 2024
Gerry Kadir BrunkDirectorAug 2024
James AdoxDirectorAug 2024
Michael BlueDirectorAug 2024
Tom Kadir TefftDirectorAug 2024
V. Kadir KadhiresanDirectorAug 2024
Wen Kadir ChenDirectorAug 2024
Fred LeeDirectorJun 2020
Gerry BrunkDirectorJun 2020
Kadir KadhiresanDirectorJun 2020
Nikita KulkarniDirectorJun 2020
Thomas TefftDirectorJun 2020
Wen ChenDirectorJun 2020
Gregory SorensenDirectorApr 2019
Tom TefftDirectorApr 2019
Andrew Christine Von EschenbachDirectorFeb 2017
Fred Christine Lee, Jr.DirectorFeb 2017
James Christine AdoxDirectorFeb 2017
Michael Christine BlueDirectorFeb 2017
Renard Christine CharityDirectorFeb 2017
Robert Christine MorffDirectorFeb 2017
M. Christine GibbonsDirectorAug 2015
Thomas Christine DavisonDirectorAug 2015